Ganciclovir
| Effect of ECMO | Minimal CS; conflicting effects on PK parameters |
|---|---|
| Dose recommendation | Standard dosing suggested |
| Comments, reference | Only 2 case reports (Int J Antimicrob Agents 2021;58:106431; J Clin Pharm Ther 2020;45:218). Therapeutic drug monitoring (if available) recommended. See also: Crit Care 2024;28:326. |